A Case of Isolated Adrenocorticotropic Hormone Deficiency Caused by Pembrolizumab

Pembrolizumab (Keytruda®) is an anti-programmed cell death 1-specific monoclonal antibody that has become the standard second-line chemotherapy for unresectable advanced microsatellite instability-high colorectal cancer. Several immune-related adverse events (irAEs), particularly endocrinopathy, are...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekki, Tomoaki, Takakura, Yuji, Kochi, Masatoshi, Konemori, Yoko, Oki, Kenji, Yoneda, Masayasu, Egi, Hiroyuki, Ohdan, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154275/
https://www.ncbi.nlm.nih.gov/pubmed/32308578
http://dx.doi.org/10.1159/000505687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154275/
https://www.ncbi.nlm.nih.gov/pubmed/32308578
http://dx.doi.org/10.1159/000505687

Ejemplares similares